Latest Helixmith News & Updates

See the latest news and media coverage for Helixmith. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Helixmith

Gene therapy development company

helixmith.com
Headquarters
Seoul, South Korea
Founded year
1996
Company type
Public company
Number of employees
50–200

Last updated

Latest news about Helixmith

In short: Helixmith initiated a new clinical trial for its diabetic neuropathy gene therapy and was identified as a key player in multiple rare disease markets.

Company announcements

Helixmith

Helixmith announces VM202 presentation at NYAS Advances in Pain Meeting

Dr. John A. Kessler presents scientific basis and Phase 3 results for VM202 in painful diabetic peripheral neuropathy on May 3, 2022. VM202 shows significant pain reduction and safety.

Unlock all announcements with a

Media coverage

Investing.com

Helixmith (KQ:084990) Annual Report

Helixmith (KQ:084990) Annual Report This summary provides an overview of the most significant critical numbers from each of the Helixmith financial reports, including the Helixmith...

Korea JoongAng Daily

Helixmith to raise 35 billion won via stock sale

Helixmith on Thursday announced that it will sell stock to raise 35 billion won ($27.3 million). The proceeds from the stock offering will be used...

Unlock all articles with a

Never miss news about Helixmith

Track Helixmith and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Helixmith competitors & trending companies

Browse news for competitors to Helixmith and other trending companies.